If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Cristian Lolli is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 5 Similar Profiles
Renal Cell Carcinoma Medicine & Life Sciences
Castration Medicine & Life Sciences
Prostatic Neoplasms Medicine & Life Sciences
Androgen Receptors Medicine & Life Sciences
Therapeutics Medicine & Life Sciences
docetaxel Medicine & Life Sciences
Survival Medicine & Life Sciences
Disease-Free Survival Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 2016 2019

CAR-T cell therapy: A potential new strategy against prostate cancer

Schepisi, G., Cursano, M. C., Casadei, C., Menna, C., Altavilla, A., Lolli, C., Cerchione, C., Paganelli, G., Santini, D., Tonini, G., Martinelli, G. & De Giorgi, U., Oct 16 2019, In : Journal for ImmunoTherapy of Cancer. 7, 1, 258.

Research output: Contribution to journalReview article

Open Access
Antigen Receptors
Cell- and Tissue-Based Therapy
Prostatic Neoplasms
Neoplasms
Antigens

Plasma androgen receptor in prostate cancer

Conteduca, V., Gurioli, G., Brighi, N., Lolli, C., Schepisi, G., Casadei, C., Burgio, S. L., Gargiulo, S., Ravaglia, G., Rossi, L., Altavilla, A., Farolfi, A., Menna, C., Colangione, S. P., Pulvirenti, M., Romeo, A. & De Giorgi, U., Nov 2019, In : Cancers. 11, 11, 1719.

Research output: Contribution to journalReview article

Open Access
Androgen Receptors
Prostatic Neoplasms
Castration
Therapeutics
Biomarkers

Plasma AR status and cabazitaxel in heavily treated metastatic castration-resistant prostate cancer

Conteduca, V., Castro, E., Wetterskog, D., Scarpi, E., Jayaram, A., Romero-Laorden, N., Olmos, D., Gurioli, G., Lolli, C., Sáez, M. I., Puente, J., Schepisi, G., Salvi, S., Wingate, A., Medina, A., Querol-Niñerola, R., Marin-Aguilera, M., Arranz, J. A., Fornarini, G., Basso, U. & 4 others, Mellado, B., Gonzalez-Billalabeitia, E., Attard, G. & De Giorgi, U., Jul 1 2019, In : European Journal of Cancer. 116, p. 158-168 11 p.

Research output: Contribution to journalArticle

Castration
Androgen Receptors
Prostatic Neoplasms
docetaxel
Disease-Free Survival

Reclassification of good-risk seminoma: Prognostic factors, novel biomarkers and implications for clinical management

Casadei, C., Schepisi, G., Menna, C., Chovanec, M., Gurioli, G., Gallà, V., Altavilla, A., Marcellini, M., Bellia, S. R., Lolli, C., Mego, M., Rosti, G. & De Giorgi, U., Apr 1 2019, In : Future Oncology. 15, 12, p. 1347-1352 6 p.

Research output: Contribution to journalArticle

Seminoma
Biomarkers
Germ Cell and Embryonal Neoplasms
Lung Diseases
Neoplasms

Testosterone levels and androgen receptor copy number variations in castration-resistant prostate cancer treated with abiraterone or enzalutamide

Lolli, C., De Lisi, D., Conteduca, V., Gurioli, G., Scarpi, E., Schepisi, G., Ravaglia, G., Menna, C., Farolfi, A., Altavilla, A., Burgio, S. L., Tonini, G., Santini, D. & De Giorgi, U., Aug 1 2019, In : Prostate. 79, 11, p. 1211-1220 10 p.

Research output: Contribution to journalArticle

Castration
Androgen Receptors
Prostatic Neoplasms
Testosterone
Disease-Free Survival